Seoulin Bioscience Co Ltd (038070) Stock Price & News

038070:KOSDAQ

Seoulin Bioscience Co Ltd

₩3,610.00

+0.70%

(+25.00) 1D

Nov 5, 9:58:16 AM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 038070...

Open

₩3,600

High

₩3,690

Low

₩3,585

Mkt. cap

33.58B

Avg. vol.

32.59K

Volume

8.31K

Dividend

2.71%

Quarterly dividend

₩24

Ex-dividend date

Dec 29, 2025

P/E ratio

36.15

52-wk high

₩7,760

52-wk low

₩3,505

EPS

₩100

Shares outstanding

9.30M

No. of employees

113

Open

₩3,600

High

₩3,690

Low

₩3,585

Mkt. cap

33.58B

Avg. vol.

32.59K

Volume

8.31K

Dividend

2.71%

Quarterly dividend

₩24

Ex-dividend date

Dec 29, 2025

P/E ratio

36.15

52-wk high

₩7,760

52-wk low

₩3,505

EPS

₩100

Shares outstanding

9.30M

No. of employees

113

News stories

From web sources and news partners

AI Insider

51 minutes ago

Agility Robotics Completes SPAC Merger Ahead of Nasdaq Debut

ChartMill

53 minutes ago

Prospect Capital (NASDAQ:PSEC) Posts Mixed Q1 as NII Beats, Revenue Misses, and Distribution Is Cut

KITV

21 minutes ago

Dow has best post-midterm elections day in 44 years as Democrats take control of Congress

PBS

4 hours ago

U.S. stocks surge, and the Dow soars 1,500 points as Brent oil's price drops below $95 per barrel

About Seoulin Bioscience Co Ltd

CEO-

Employees113

Founded1984

Headquarters-

SectorBiotechnology

Industry-

Websiteseoulin.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	22.87B	19.96B	19.53B	20.80B
Cost of goods sold	17.75B	15.42B	15.08B	17.17B
Cost of revenue	17.75B	15.42B	15.08B	17.17B
Research and development expenses	238.24M	151.88M	212.16M	256.80M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.46B	4.04B	3.58B	3.43B
Operating expense	4.34B	4.40B	4.28B	4.23B
Total operating expenses	22.09B	19.82B	19.35B	21.40B
Operating income	784.70M	142.28M	174.55M	-597.45M
Other non operating income	15.28M	533.61M	43.66M	1.52B
EBT including unusual items	776.92M	-391.36M	154.36M	452.87M
EBT excluding unusual items	753.24M	490.88M	147.40M	895.85M
Income tax expense	21.67M	12.84M	2.95M	110.66M
Effective tax rate	2.79%	-3.28%	1.91%	24.43%
Other operating expenses	145.64M	86.57M	143.51M	130.62M
Net income	766.94M	-355.69M	163.16M	342.21M
Net profit margin	3.35%	-1.78%	0.84%	1.65%
Earnings per share	-	-	-	-
Interest and investment income	220.26M	236.78M	229.38M	228.24M
Interest expense	-280.56M	-295.65M	-340.19M	-364.11M
Net interest expenses	-60.30M	-58.87M	-110.81M	-135.86M
Depreciation and amortization charges	242.48M	247.26M	264.16M	290.14M
EBITDA	1.06B	426.51M	474.74M	-272.42M
Gain or loss from assets sale	-	-	-	3.00K

Finance

Ask anything